lisdexamfetamine dimesylate 20 MG Chewable Tablet [Vyvanse]

RxNorm concept 1871463, branded drug (sbd). Prescribable name: Vyvanse 20 MG Chewable Tablet.

RxCUI: 1871463
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/1871463 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

lisdexamfetamine 700810

Other names

Vyvanse 20 MG Chewable Tablet

Related concepts

lisdexamfetamine dimesylate 20 MG (SCDC, consists of)
lisdexamfetamine dimesylate 20 MG [Vyvanse] (SBDC, consists of)
Chewable Tablet (DF, has dose form)
Vyvanse (BN, has ingredient)
lisdexamfetamine dimesylate 20 MG Chewable Tablet (SCD, tradename of)

Linked data

NDCs

59417011601

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 1871463 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/1871463 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 1871463. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.